2 Einträge gefunden

1. Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies

   1. Kimball, A B
   2. Papp, K A
   3. Reich, K
   4. Gooderham, M
   5. Li, Q
   6. Cichanowitz, N
   7. La Rosa, C

   2020 - Forschungsinformationssystem des UKE
2. Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab

   1. Kimball, A B
   2. Kerbusch, T
   3. van Aarle, F
   4. Kulkarni, P
   5. Li, Q
   6. Blauvelt, A
   7. Papp, K A

   2020 - Forschungsinformationssystem des UKE